Guidance on prevention of viral hepatitis B and C among people who inject drugs

The guidance is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World Health Organization. The following recommendations are based on systematic reviews of scientific evidence, community values and preferences and implementat...

Full description

Bibliographic Details
Corporate Authors: World Health Organization, World Health Organization Department of HIV/AIDS.
Format: eBook
Language:English
Published: Geneva World Health Organization [2012], 2012
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02205nam a2200289 u 4500
001 EB000943691
003 EBX01000000000000000737281
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
020 |a 9789241504041 
245 0 0 |a Guidance on prevention of viral hepatitis B and C among people who inject drugs  |h Elektronische Ressource  |c World Health Organization 
260 |a Geneva  |b World Health Organization  |c [2012], 2012 
300 |a 1 PDF file (46 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Hepatitis B / prevention & control 
653 |a Hepatitis C / prevention & control 
653 |a Substance Abuse, Intravenous / complications 
653 |a Disease Transmission, Infectious / prevention & control 
710 2 |a World Health Organization 
710 2 |a World Health Organization  |b Department of HIV/AIDS. 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
500 |a Title from PDF title page. - "July 2012.". - "HIV/AIDS Programme." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK144127  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a The guidance is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World Health Organization. The following recommendations are based on systematic reviews of scientific evidence, community values and preferences and implementation issues. Recommendation 1: It is suggested to offer people who inject drugs the rapid hepatitis B vaccination regimen. Recommendation 2: It is suggested to offer people who inject drugs incentives to increase uptake and completion of the hepatitis B vaccine schedule. Recommendation 3: It is suggested that needle and syringe programs also provide low dead-space syringes for distribution to people who inject drugs. Recommendation 4: Psychosocial interventions are not suggested for people who inject drugs to reduce the incidence of viral hepatitis. Recommendation 5: It is suggested to offer peer interventions to people who inject drugs to reduce the incidence of viral hepatitis